Meningococcal serogroup A avidity indices as a surrogate marker of priming for the induction of immunologic memory after vaccination with a meningococcal A/C conjugate vaccine in infants in the United Kingdom

Journal of Infectious Diseases

Volumn 184, Issue 5, 2001, Pages 661-662

  Feavers, Ian ^d   Andrews, Nick ^c  

^a WITHINGTON HOSPITAL   (United Kingdom)

^b MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE;

HUMAN; IMMUNOSTIMULATION; INFECTION PREVENTION; LETTER; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; UNITED KINGDOM; VACCINATION;

ANTIBODIES, BACTERIAL; ANTIBODY AFFINITY; GREAT BRITAIN; HUMANS; IMMUNOLOGIC MEMORY; INFANT; INFANT, NEWBORN; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; POLYSACCHARIDES, BACTERIAL; VACCINATION; VACCINES, CONJUGATE;

EID: 0035450073     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/322790     Document Type: Letter

References (7)

1. Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers
2. Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization
3. Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine
4. Induction of immunological memory in UK infants by a meningococcal A/C conjugate vaccine
5. Conjugate meningococcal serogroup A and C vaccine: Reactogenicity and immunogenicity in United Kingdom infants
6. Meningococcal serogroup C-specific IgG antibody responses and serum bactericidal titers in children following vaccination with a meningococcal A/C polysaccharide vaccine
7. Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines